Please assess the completion status of the following clinical trial:

Trial Title: All-Case Surveillance of Prizbind®

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~Patients who are prescribed with Prizbind® for Intravenous Solution 2.5 g by the discretion of investigators~Exclusion criteria:~None

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Prizbind® for Intravenous Solution (Type: None): Patients treated with dabigatran etexilate who have uncontrolled bleeding or require emergency surgery or procedures.

Based on this trial design, predict the completion outcome and termination type (if applicable).